Was the Corteva (CTVA) share grant to Janet Plaut Giesselman an open-market purchase?

No, the transaction was not an open-market purchase. It was coded as a grant or award of 2,350 Corteva common shares at $0.00 per share, indicating a compensation-related acquisition rather than shares bought in the market at prevailing trading prices.

Does Janet Plaut Giesselman’s Corteva (CTVA) Form 4 show any share sales?

The Form 4 does not show any sales. It reports one acquisition transaction coded as a grant or award of 2,350 Corteva common shares, with no disposition or sale codes, so the filing reflects only an increase in her reported direct ownership position.

Corteva director granted 2,350 company shares

Corteva, Inc. director Janet Plaut Giesselman reported receiving a grant of 2,350 shares of Common Stock at no cost.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Corteva, Inc. director Janet Plaut Giesselman reported receiving a grant of 2,350 shares of Common Stock at no cost. This compensation-related award increased her direct holdings to 20,006.9028 shares of Corteva stock. A footnote notes that this amount includes 39.0792 shares acquired through dividend reinvestment, reflecting automatic reinvestment of dividends rather than open-market buying.

Insider Trade Summary

Grant/Award: 2,350 shares

Grant/Award 1 txn

Insider Giesselman Janet Plaut

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,350	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,006.9028 shares (Direct)

Footnotes (1)

F1. Includes acquisition of 39.0792 shares pursuant to dividend reinvestment.

Key Figures

Stock grant size: 2,350 shares Price per granted share: $0.00 per share Total holdings after transaction: 20,006.9028 shares +1 more

4 metrics

Stock grant size 2,350 shares Common Stock grant coded as acquisition (A)

Price per granted share $0.00 per share Indicates compensation-related stock award, not market purchase

Total holdings after transaction 20,006.9028 shares Director’s direct Corteva Common Stock position after grant

Dividend reinvestment shares 39.0792 shares Shares acquired via dividend reinvestment included in holdings

Key Terms

Common Stock, Grant, award, or other acquisition, dividend reinvestment, Form 4

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

dividend reinvestment financial

"Includes acquisition of 39.0792 shares pursuant to dividend reinvestment."

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Corteva (CTVA) director Janet Plaut Giesselman report?

Director Janet Plaut Giesselman reported receiving a grant of 2,350 Corteva common shares. The award was recorded at a price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase, and it increased her direct ownership position in the company.

How many Corteva (CTVA) shares does Janet Plaut Giesselman hold after this Form 4?

After the reported transaction, Janet Plaut Giesselman directly holds 20,006.9028 Corteva common shares. This total reflects her updated position following the 2,350-share grant and includes additional fractional shares attributed to dividend reinvestment activity disclosed in the filing footnote.

What does the dividend reinvestment footnote mean in Janet Plaut Giesselman’s Corteva (CTVA) filing?

The footnote states that her holdings include 39.0792 shares acquired through dividend reinvestment. This means cash dividends on Corteva stock were automatically used to buy additional fractional shares, modestly increasing her position without separate open-market transactions by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/30/2026 - 05:38 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Giesselman Janet Plaut

(Last)

(First)

(Middle)

C/O CORTEVA, INC.

9330 ZIONSVILLE ROAD

(Street)

INDIANAPOLIS

INDIANA

46268

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Corteva, Inc. [ CTVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/28/2026		A		2,350	A	$0	20,006.9028⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes acquisition of 39.0792 shares pursuant to dividend reinvestment.

	/s/Abigail Jarrell, by power-of-attorney	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR